English
Home > Products > Letermovir N-3

China Letermovir N-3 Factory

To constantly improve the management system by virtue of the rule of "sincerely, good faith and quality are the base of enterprise development", we widely absorb the essence of related products internationally, and constantly develop new products to meet the demands of customers for Letermovir N-3,CAS NO 917389-26-5,917389-26-5,Letermovir intermediate,Letermovir advance intermediate, We warmly welcome you to set up cooperation and generate a bright long term together with us.
Letermovir N-3, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Related Products

Hot Products

  • 6-chloro-2-methyl-2H-indazol-5-amine

    6-chloro-2-methyl-2H-indazol-5-amine

    Product Name:6-chloro-2-methyl-2H-indazol-5-amine
    Molecular Formula:C8H8ClN3
    Molecular Weight:181.62
    CAS Registry Number:1893125-36-4
  • Mandelic acid

    Mandelic acid

    Product Name:Mandelic acid
    Molecular Formula:C8H8O3
    Molecular Weight:152.15
    CAS Registry Number:611-71-2
  • Troxerutin

    Troxerutin

    Product Name:Troxerutin
    Molecular Formula:C33H42O19
    Molecular Weight;742.68
    CAS Registry Number;7085-55-4
  • L-Valine methyl ester hydrochloride

    L-Valine methyl ester hydrochloride

    Product Name:L-Valine methyl ester hydrochloride
    Molecular Formula:C6H14ClNO2
    Molecular Weight:167.63
    CAS Registry Number:6306-52-1
  • 2,2,2-Trichloroethyl chloroformate

    2,2,2-Trichloroethyl chloroformate

    Product Name:2,2,2-Trichloroethyl chloroformate
    Molecular Formula:C3H2Cl4O2
    Molecular Weight:211.86
    CAS Registry Number:17341-93-4
  • Parecoxib Sodium

    Parecoxib Sodium

    Product Name:Parecoxib Sodium
    Molecular Formula:C19H19N2NaO4S
    Molecular Weight;394.42
    CAS Registry Number;198470-85-8
  • Related Blog
  • Reviews

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept